Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
about
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Alternative-splicing defects i ...... to novel cancer therapeutics.
@en
Alternative-splicing defects i ...... to novel cancer therapeutics.
@nl
type
label
Alternative-splicing defects i ...... to novel cancer therapeutics.
@en
Alternative-splicing defects i ...... to novel cancer therapeutics.
@nl
prefLabel
Alternative-splicing defects i ...... to novel cancer therapeutics.
@en
Alternative-splicing defects i ...... to novel cancer therapeutics.
@nl
P2093
P2860
P356
P1476
Alternative-splicing defects i ...... to novel cancer therapeutics.
@en
P2093
Laura M Urbanski
Nathan Leclair
Olga Anczuków
P2860
P356
10.1002/WRNA.1476
P577
2018-04-25T00:00:00Z